DARIOHEALTH CORP.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$5M
↓-31.2% -$2Mvs FY2024 (Q4)
Gross Profit
$3M
↓-33.3% -$1Mvs FY2024 (Q4)
Operating Income
$110K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $5M | $8M |
| COGS | $2M | $3M |
| Gross Profit | $3M | $4M |
| R&D | $3M | $5M |
| SG&A | $0 | $0 |
| D&A | $60K | $554K |
| Other OpEx | $0 | $0 |
| Operating Income | $110K | $0 |
| Interest Exp. | $110K | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · DRIO · Comparing FY2025 (Q4) vs FY2024 (Q4)